SoftServ's capabilities include full stack software development; security, accessibility and disaster recovery audits; mobile app development; containerization; Scientist.com marketplace configurations; and more.
SoftServ was created by Scientist.com's acquisition of Notch8 in Dec 2021. That same year, Scientist.com purchased HealthEconomics.Com, the world's largest Connected Community for the Value, Evidence and Market Access industry; InsideScientific, an online marketing content creator for the life sciences; and BioPharmCatalyst, a research-based portal that provides key catalyst updates for publicly traded biotech companies.
Scientist.com operates online marketplaces for most of the world's top 30 pharmaceutical companies, 120+ biotech companies and the US National Institutes of Health. The award-winning digital research platform helps life scientists test more ideas in less time.
Scientist.com's mission is to empower and connect scientists worldwide.
The company's digital research platform combines a custom-built, cloud native technology stack with white-glove customer and scientific support to enable scientists to run more innovative experiments in less time and at lower cost.
Scientist.com leverages internally developed machine learning models to provide actionable insights that improve operational efficiency and effective research management.
Scientist.com connects researchers at the world's top pharmaceutical companies, biotechnology companies, and the US National Institutes of Health to the world's largest network of scientific research suppliers.
GSK releases decade-long data on Shingrix efficacy
GSK announces positive EAGLE-1 results for gepotidacin in gonorrhoea treatment
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
Charles River Laboratories launches AMAP to reduce animal testing reliance
PureTech completes enrollment in Phase 2b ELEVATE IPF trial for LYT-100
Cybin secures additional US patent for CYB003 breakthrough therapy programme
UroGen's UGN-103 IND accepted by FDA for bladder cancer treatment
Biophytis reinforces obesity IP with new patent application
MaaT Pharma reveals positive 18-month data for MaaT013 in GI-aGvHD
Fusion Antibodies plc secures contract for OptiPhage library development
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients